Cetera Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,966
Closed -$233K 1703
2022
Q4
$233K Buy
2,966
+104
+4% +$7.99K ﹤0.01% 1364
2022
Q3
$204K Sell
2,862
-233
-8% -$17.4K 0.01% 1139
2022
Q2
$232K Sell
3,095
-199
-6% -$15.1K 0.01% 1164
2022
Q1
$262K Sell
3,294
-312
-9% -$24.2K 0.01% 1169
2021
Q4
$293K Sell
3,606
-3,362
-48% -$266K 0.01% 1130
2021
Q3
$539K Buy
6,968
+2,647
+61% +$213K 0.01% 856
2021
Q2
$348K Buy
4,321
+1
+0% +$79 0.01% 984
2021
Q1
$341K Buy
4,320
+496
+13% +$38.7K 0.01% 898
2020
Q4
$273K Buy
3,824
+317
+9% +$21.2K 0.01% 859
2020
Q3
$224K Buy
3,507
+50
+1% +$3.27K 0.01% 843
2020
Q2
$224K Buy
+3,457
New +$215K 0.01% 809
2019
Q2
Sell
-434
Closed -$28K 1184
2019
Q1
$28K Buy
+434
New +$28.5K ﹤0.01% 1044
2015
Q3
Sell
-2,564
Closed -$203K 734
2015
Q2
$203K Sell
2,564
-2,404
-48% -$187K 0.02% 652
2015
Q1
$378K Hold
4,968
0.03% 443
2014
Q4
$332K Buy
4,968
+1,500
+43% +$99.9K 0.03% 458
2014
Q3
$221K Sell
3,468
-400
-10% -$24.7K 0.02% 523
2014
Q2
$236K Buy
+3,868
New +$224K 0.03% 500

Other funds holding PJP

Cetera Advisors's PJP Position: Q1 2023 in Review

Cetera Advisors sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2023, closing a stake of 2,966 shares — an estimated $233K sold.

Cetera Advisors first reported a position in PJP in Q2 2014 and held it in 17 quarters. The position peaked at $539K in Q3 2021. 87 funds tracked by Wall St. Rank hold PJP as of Q1 2023.

  • Cetera Advisors reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2023 after selling out during the quarter.
  • Cetera Advisors sold 2,966 Invesco Pharmaceuticals ETF shares in Q1 2023, an estimated $233K.
  • Cetera Advisors first reported a position in Invesco Pharmaceuticals ETF in Q2 2014 and held it in 17 quarters.
  • Cetera Advisors's Invesco Pharmaceuticals ETF position peaked at $539K in Q3 2021.
  • 87 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2023.

Based on Cetera Advisors's 13F filing for Q1 2023, filed 15 May 2023.